Left Atrial Appendage Closure Device Market Growth Outlook Through 2024-2033

Spread the love

Overview and Scope

A left atrial appendage closure device is a medical implant used to treat certain heart conditions, specifically in atrial fibrillation (AF) patients. These devices are implanted in a minimally invasive surgery to lower the risk of stroke in AF patients by sealing off or occluding the left atrial appendage (LAA), preventing blood from entering and clotting.

Sizing and Forecast

The left atrial appendage closure device market size has grown exponentially in recent years. It will grow from $1.39 billion in 2023 to $1.67 billion in 2024 at a compound annual growth rate (CAGR) of 20.1%. The growth in the historic period can be attributed to prevalence of atrial fibrillation, stroke prevention strategies, clinical evidence and research, minimally invasive alternatives, patient preference for non-pharmacological options, aging population, physician training and expertise..

The left atrial appendage closure device market size is expected to see rapid growth in the next few years. It will grow to $3.21 billion in 2028 at a compound annual growth rate (CAGR) of 17.7%. The growth in the forecast period can be attributed to rising global burden of atrial fibrillation, focus on stroke prevention in high-risk patients, expanding patient awareness, integration into standard clinical practice, global efforts in cardiovascular disease management.. Major trends in the forecast period include emergence of percutaneous closure techniques, advancements in device designs, increasing use of imaging technologies, focus on minimally invasive approaches, tailored device selection for patient anatomy..

Order your report now for swift delivery, visit the link:

https://www.thebusinessresearchcompany.com/report/left-atrial-appendage-closure-device-global-market-report

Segmentation & Regional Insights

The left atrial appendage closure device market covered in this report is segmented –

1) By Product: Epicardial Left Atrial Appendage (LAA) Devices, Endocardial Left Atrial Appendage (LAA) Devices
2) By Procedure: Percutaneous, Surgical
3) By End-User: Hospital, Ambulatory Surgical Centers, Other End-Users

North America was the largest region in the left atrial appendage closure devices market in 2023. The regions covered in the left atrial appendage closure device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13474&type=smp

Major Driver Impacting Market Growth

The rising prevalence of atrial fibrillation is expected to propel the growth of the left atrial appendage (LAA) closure device market going forward. Atrial fibrillation is a medical condition characterized by an irregular and often rapid heartbeat. It occurs when the heart’s upper chambers, called the atria, do not beat in a coordinated and rhythmic manner. Left atrial appendage (LAA) closure devices are primarily used in treating atrial fibrillation by reducing the risk of stroke in patients with this cardiac arrhythmia and preventing blood clots from forming or escaping. For instance, in October 2022, according to reports published by the Centers for Disease Control and Prevention, a US-based government agency, atrial fibrillation was the predominant diagnosis in more than 454,000 hospital admissions each year in the US, and it is expected that 12.1 million people in the US will have atrial fibrillation in 2030. Therefore, the rising prevalence of atrial fibrillation is expected to propel the growth of the left atrial appendage (LAA) closure device market.

Key Industry Players

Major companies operating in the left atrial appendage closure device market report are Johnson And Johnson Pvt Ltd., Abbott Laboratories , Medtronic plc., Atrium Medical Corporation, Boston Scientific Corporation, Gore Medical Inc., Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, AtriCure Inc., Dune Medical Devices Ltd., Lifetech Scientific Corporation, Sahajanand Medical Technologies Limited , Occlutech, Cardiva Medical Inc., Sentreheart Inc., Aegis Medical Group, Coherex Medical Inc., EndoStim Inc., Conformal Medical Inc., Cardia Inc., Medical Device Business Service Inc., Protaryx Medical, Append Medical Ltd, Vascular Innovations Co. Ltd., Vivasure Medical Inc., Atritech Inc., CardiaMed AB, Cardialen Inc., Kalila Medical Inc.</b

The left atrial appendage closure device market report table of contents includes:

1. Executive Summary
2. Left Atrial Appendage Closure Device Market Characteristics
3. Left Atrial Appendage Closure Device Market Trends And Strategies
4. Left Atrial Appendage Closure Device Market – Macro Economic Scenario
5. Global Left Atrial Appendage Closure Device Market Size and Growth
.
.
.
32. Global Left Atrial Appendage Closure Device Market Competitive Benchmarking
33. Global Left Atrial Appendage Closure Device Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Left Atrial Appendage Closure Device Market
35. Left Atrial Appendage Closure Device Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model


Spread the love

About Top PR News

TopPRnews Leads Drives Search Engine Visibility For Your Press Release Content. Our Global Network Reaches Important Contacts, Media Partners And Websites And Journalists. Happy Postings! If You Have Any Queries Please Contact Official Mail At [[email protected]}

View all posts by Top PR News →